Biomerica Q1 2026 Earnings Net Loss of 044 Per Share Amid Lack of Revenue Disclosure EGO Q1 2026 Earnings Stellar EPS Beat Drives Investor Caution Despite Strong Operational Performance SPAI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Crown Castle Q1 2026 Earnings EPS Misses Estimates by 133 Stock Declines Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment ALLT Q1 2026 Earnings EPS Surpasses Estimates by 3575 Despite Flat Stock Response